Viridian Therapeutics, Inc.\DE (VRDN) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Viridian Therapeutics, Inc.\DE (VRDN) over the last 11 years, with Q4 2024 value amounting to $540000.0.
- Viridian Therapeutics, Inc.\DE's Accumulated Depreciation & Amortization rose 344.83% to $540000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $540000.0, marking a year-over-year increase of 344.83%. This contributed to the annual value of $540000.0 for FY2024, which is 344.83% up from last year.
- Viridian Therapeutics, Inc.\DE's Accumulated Depreciation & Amortization amounted to $540000.0 in Q4 2024, which was up 344.83% from $522000.0 recorded in Q4 2023.
- In the past 5 years, Viridian Therapeutics, Inc.\DE's Accumulated Depreciation & Amortization registered a high of $540000.0 during Q4 2024, and its lowest value of $25000.0 during Q2 2021.
- For the 5-year period, Viridian Therapeutics, Inc.\DE's Accumulated Depreciation & Amortization averaged around $181636.4, with its median value being $68000.0 (2020).
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first plummeted by 6093.75% in 2021, then soared by 15000.0% in 2022.
- Quarter analysis of 5 years shows Viridian Therapeutics, Inc.\DE's Accumulated Depreciation & Amortization stood at $239000.0 in 2020, then crashed by 49.79% to $120000.0 in 2021, then skyrocketed by 150.0% to $300000.0 in 2022, then soared by 74.0% to $522000.0 in 2023, then increased by 3.45% to $540000.0 in 2024.
- Its Accumulated Depreciation & Amortization stands at $540000.0 for Q4 2024, versus $522000.0 for Q4 2023 and $300000.0 for Q4 2022.